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Submitted Sep 24, 2013; accepted Jan 21, 2014.DISCUSSIONDr John Ricotta (Washington, D.C.). Do you have any data
on your perioperative anticoagulation protocol? Do you think
you’re sending your patients home too quickly? Your average
length of stay is 1 day and perhaps this affects your readmission
rate.
Dr Karen J. Ho. This cohort includes the patients of 10 sur-
geons, and virtually all of them give protamine at the end of the
case. Our rate of bleeding complications has decreased over the
10-year study period, possibly because of the initiation of prot-
amine. I think the higher rate of hematoma and bleeding that
we report partially reﬂects the period of time before we were using
protamine regularly.
Dr Ricotta. I just wonder whether maybe the pendulum has
gone a little too far in one direction. Why don’t you answer that
question and then we’ll get Dr Moore.
Dr Ho. The mean postoperative length of stay of this cohort
was 2.4 days with a range of 1 to 66 days. Using this same patient
cohort, we know that increased length of stay is not associated with
decreasing unplanned readmissions.
Dr Wesley Moore (Los Angeles, Calif). I have just one ques-
tion. I noted that you were only capturing readmission to your
own hospital. In my institution, I have patients coming from a
fair distance away, and I suspect that must be true in your institu-
tion as well when you’re looking at the experience in a tertiary care
medical center. I’m wondering if you’re missing readmissions to
other hospitals, and would it be possible to go back and ﬁnd out
that information as well?
DrHo. That’s a very good point. It’s one of the weaknesses of
a single-center cohort study. Our rate of unplanned readmission is
6.5%. The unplanned readmission rate from a VA study that was
published in 2004 was 4%. The readmission rate from the 2011
NSQIP database, which includes readmission data for the ﬁrst
time, is approximately 7%. And a paper that was presented at theMidwestern Vascular Society last year reported an unplanned read-
mission rate of 8.8% in a Medicare database. So I think even
though we are not capturing readmissions that perhaps went to
another hospital, our readmission rate is still comparable to
contemporary estimates.
We could potentially go back to the charts and see if there are
any mentions of readmissions to other centers, but my gut feeling
is that patients tend to want to be seen by their surgeon for any
problems that occur in the ﬁrst month postop.
Dr Marat Goldenberg (Cartersville, Ga). Have you looked
at the difﬁculty in stabilizing blood pressure postoperatively within
the ﬁrst 24 hours and correlate that with an appearance of compli-
cation or problems whether they result in admissions or not? And if
blood pressure was difﬁcult to control, either high or low, should
the patient be kept in the hospital for an extra day?
Dr Ho. It’s our routine practice to be very aggressive about
maintaining systolic blood pressure between 100 and 140 mm
Hg. We typically do not discharge patients until their blood pres-
sure is stable within these parameters on an oral medication
regimen. A third of our patients went home with a visiting nurse
and usually that’s for either wound checks or for blood pressure
checks. We also have a care coordinator who calls patients post
discharge day 1 to check on those issues.
Dr Krishnasamy Soundararajan (Wilmington, Del). I was
interested in the group which was admitted for headache. It is
generally believed that the chances of reperfusion symptoms are
higher in patients with contralateral occlusion or high-grade steno-
sis. Would you be able to elaborate if you had looked into or if it is
worth looking into the status of the contralateral carotid perfusion
in those patients with headache?
Dr Ho. The reason why we are very aggressive about readmit-
ting patients with headache and not discharging patients who
report a headache is that we are concerned about cerebral
JOURNAL OF VASCULAR SURGERY
84 Ho et al July 2014hyperperfusion. We have not looked at contralateral carotid occlu-
sion and the incidence of headache.
Dr Matthew Sweet (Seattle, Wash). In light of the discus-
sion about the beneﬁt of carotid endarterectomy in asymptomatic
patients, can you infer anything about the patients who had post-
operative CHF in terms of helping to better risk stratify patients
before the operation? Have these data changed the practice
pattern at your hospital, or are there any other lessons we can
take away on who maybe shouldn’t have an asymptomatic carotid
endarterectomy?Dr Ho. I think we all know that the rate of readmission for
patients with CHF is very high. Nationally the average readmis-
sion rate is on the order of 20% to 24%. I looked up our hospital’s
readmission rate for CHF patients and it matches the national
average.
I think that once one has determined that a patient is at risk
for a postop complication but potentially could also beneﬁt from
the surgery, I think one has to accept that there is a risk/beneﬁt
ratio to everything one does, understand the factors that contribute
to risk, and try to minimize them to the best of one’s ability.
